Trading Signals: HALO Stock Price Prediction and Forecast (Mon. Aug. 10, 2015 - Wed. Sep. 27, 2023)(Halozyme Therapeutics Inc)
| HALO latest price $28.0500 (-0.78%) ($27.9900 - $28.5900) on Wed. Aug. 26, 2020. | |
| | Trend Analysis and Forecast | | | Average Daily Percentage Swing | 2.31% (three month average) | RSI | 40 | Latest Price | $28.0500(-0.78%) | Stocks Behave Similarly | Similar Stock List | Daily Trend | HALO declines -0.2% a day on average for past five trading days. | Weekly Trend | HALO declines -1% a week on average for past two weeks. | Market Behavior | Growth stock rally for large cap. Value stock sell-off for small cap. | Correlated ETFs | Broad market will support HALO advance at 0% a week (0% probability) IWO(50%) IBB(49%) IWM(48%) IWC(45%) ARKG(42%) | Factors Impacting HALO price | HALO will decline at least -1.155% in a week (0% probabilities). VIXM(-31%) UUP(-15%) VXX(-14%) EDOC(-3%) TLT(-2%) | | | | | Relative Volatility | (options are extremely cheap) | | | Market Trend Strength | -1.155% (StdDev 2.31%) | Hourly BBV | 0.3 () | Intraday Trend | 0% | | | |
|
Inflection Point | Yes | Resistance Level | $28.36 | 5 Day Moving Average | $28.17(-0.43%) | 10 Day Moving Average | $28.28(-0.81%) | 20 Day Moving Average | $28.36(-1.09%) | To recent high | -5.3% | To recent low | 22.9% | Market Cap | $3.834b | | | | Halozyme Therapeutics, Inc. is a biopharmaceutical company, which engages in research, development & commercialization of human enzymes and drug candidates. It focuses on novel oncology therapies that target the tumor microenvironment. Its products include PEGPH20, HTI-1511, PEG-ADA2, and HYLENEX recombinant. The company was founded by Gregory Ian Frost on February 26, 1998 and is headquartered in San Diego, CA. |